Tech Company Financing Transactions
ALTATHERA Pharmaceuticals Funding Round
Private investors participated in a $500 thousand venture round for ALTATHERA Pharmaceuticals. The round was announced on 2/2/2015.
Transaction Overview
Company Name
Announced On
2/2/2015
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 South Wacker Dr. 3100
Chicago, IL 60606
USA
Chicago, IL 60606
USA
Phone
Website
Email Address
Not Recorded
Overview
AltaThera Pharmaceuticals is a specialty pharmaceutical company focused on critical care and alternative therapeutics for unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jodi Devlin
Chief Financial Officer
James Scully
General Manager
John Ellis
VP - Bus. Development
Brandon Kashfian
VP - General Counsel
Stephen O'Sullivan
VP - Regulatory Affairs
John Somberg
VP - Sales
Scott Gaito
Browse more venture capital transactions:
Prev: 2/2/2015: Revinate venture capital transaction
Next: 2/2/2015: Amyris venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs